Shares of MedX Health Corp (CVE:MDX – Get Free Report) hit a new 52-week low on Thursday. The stock traded as low as C$0.04 and last traded at C$0.04, with a volume of 41,000 shares changing hands. The stock had previously closed at C$0.04.
MedX Health Price Performance
The stock has a 50-day simple moving average of C$0.05 and a 200 day simple moving average of C$0.05. The company has a market cap of C$13.12 million, a PE ratio of -2.00 and a beta of 0.21.
MedX Health Company Profile
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
See Also
- Five stocks we like better than MedX Health
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
